Source: UK Health Security Agency
This UKHSA report provides an overview of the recent epidemiology of hepatitis C in London, focusing on trends, risk factors, and population groups at higher risk. It covers data up to the end of 2022.
In 2022, London reported a significant number of new hepatitis C cases, accounting for 31% of England’s total, with the highest incidence rates observed in specific local authorities like Lambeth. The report notes that the increase in reported cases may be linked to enhanced testing efforts, including opt-out testing in emergency departments. Injecting drug use remains the primary risk factor for hepatitis C, with 64% of people who have ever injected drugs in London testing positive for anti-HCV antibodies. However, the rate of current infections among this group has decreased, likely due to improved testing and treatment access.
The report also highlights disparities in hepatitis C incidence across different demographics and socioeconomic groups, with the highest rates observed among males aged 35 to 54 years and those in the most deprived areas. Despite progress in reducing mortality and increasing treatment success rates, challenges remain, particularly in ensuring adequate needle and syringe provision and access to harm reduction services.